Åslaug Helland
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 52
- Lung Cancer Diagnosis and Treatment 33
- Oncology 63
- Cancer Immunotherapy and Biomarkers 27
- Lung Cancer Research Studies 26
- Co-authors
- Odd Terje Brustugun (60 shared papers)Anne‐Lise Børresen‐Dale (42 shared papers)Julien Mazières (8 shared papers)Gunnar Balle Kristensen (18 shared papers)Bruce Evan Johnson (2 shared papers)David Planchard (2 shared papers)Benjamin Besse (3 shared papers)Vanessa Giannone (2 shared papers)
- Journals
- Annals of Oncology (22 papers)Molecular Oncology (17 papers)Acta Oncologica (17 papers)Journal of Thoracic Oncology (14 papers)Frontiers in Oncology (9 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Åslaug Helland
219 papers receiving 9.5k citations
Åslaug Helland's Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 1.7k
- Oncology 2.3k
- Pulmonary and Respiratory Medicine 2.7k
- Molecular Biology 1.9k
- Reproductive Medicine 276
Countries citing papers authored by Åslaug Helland
This map shows the geographic impact of Åslaug Helland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åslaug Helland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åslaug Helland more than expected).
Fields of papers citing papers by Åslaug Helland
This network shows the impact of papers produced by Åslaug Helland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åslaug Helland. The network helps show where Åslaug Helland may publish in the future.
Co-authors
The 25 scholars most cited alongside Åslaug Helland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial Hit paper breakdown → | 2017 | 1094 |
| 2 | 2006 | 517 | |
| 3 | Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer Hit paper breakdown → | 2011 | 400 |
| 4 | 2016 | 304 | |
| 5 | 2018 | 304 | |
| 6 | 2015 | 268 | |
| 7 | 2018 | 265 | |
| 8 | 2019 | 262 | |
| 9 | 2014 | 250 | |
| 10 | 2014 | 227 | |
| 11 | 2011 | 167 | |
| 12 | 2009 | 154 | |
| 13 | 2014 | 152 | |
| 14 | 2015 | 148 | |
| 15 | 2021 | 142 | |
| 16 | 2009 | 136 | |
| 17 | 2014 | 135 | |
| 18 | 2011 | 130 | |
| 19 | 2011 | 128 | |
| 20 | 2016 | 125 |
About Åslaug Helland
Åslaug Helland is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Reproductive Medicine and Molecular Biology, having authored 228 papers that have together received 9.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (52 papers), Lung Cancer Diagnosis and Treatment (33 papers), Cancer Immunotherapy and Biomarkers (27 papers), Lung Cancer Research Studies (26 papers), Cancer Genomics and Diagnostics (25 papers), Epigenetics and DNA Methylation (18 papers), Cervical Cancer and HPV Research (16 papers) and Ovarian cancer diagnosis and treatment (10 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.3k citations), Pulmonary and Respiratory Medicine (2.7k citations), Molecular Biology (1.9k citations) and Reproductive Medicine (276 citations). Åslaug Helland has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Odd Terje Brustugun, Anne‐Lise Børresen‐Dale, Julien Mazières, Gunnar Balle Kristensen, Bruce Evan Johnson, David Planchard, Benjamin Besse, Vanessa Giannone, Egbert Frederik Smit and Harry J.M. Groen. Their work appears in journals such as Annals of Oncology, Molecular Oncology, Acta Oncologica, Journal of Thoracic Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.